A Clinical Outcomes and Cost Analysis Comparing Photoselective Vaporization of the Prostate to Alternative Minimally Invasive Therapies and Transurethral Prostate Resection for the Treatment of Benign Prostatic Hyperplasia

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1500-1506

  Stovsky, Mark D ^a   Griffiths, Robert I ^b,c   Duff, Steven B ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Health Economics Consulting   (United States)

^d Veritas Health Economics Consulting Inc   (United States)

Author keywords

costs and cost analysis; outcome assessment (health care); prostate; prostatic hyperplasia

Indexed keywords

ARTICLE; BLADDER NECK STENOSIS; BLADDER OBSTRUCTION; COST BENEFIT ANALYSIS; DYSURIA; ERECTILE DYSFUNCTION; FOLLOW UP; HEMATURIA; HUMAN; IMPOTENCE; INCONTINENCE; INTERMETHOD COMPARISON; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; PHOTOSELECTIVE VAPORIZATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SENSITIVITY ANALYSIS; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE RETENTION; UROFLOWMETRY;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; LASER SURGERY; MALE; MODELS, ECONOMIC; PROSTATIC HYPERPLASIA; RETREATMENT; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 33748100066     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.064     Document Type: Article

References (35)

1. McConnell J.D., Roehrborn C.G., Bautista O.M., et al. The long term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349 (2003) 2387
2. Kirby R.S., Roehrborn C.G., Boyle P., et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia. the Prospective European Doxazosin and Combination Therapy (PREDICT) Trial. Urology 61 (2003) 119
3. Lepor H., Williford W.O., Barry M.J., et al. The Efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 335 (1996) 533
4. Management of BPH (2003). American Urological Association. Available at http://www.auanet.org/guidelines/bph.cfm. Accessed October 2005
5. Centers for Medicare and Medicaid Services Calendar Year 2005 Inpatient Prospective Payment System Final Rule (2004), Federal Register, Washington, D. C October 7
6. Centers for Medicare and Medicaid Services Calendar Year 2005 Medicare Physician Fee Schedule Final Rule (2004), Federal Register, Washington, D. C November 15
7. Centers for Medicare and Medicaid Services Calendar Year 2005 Hospital Outpatient Prospective Payment System Final Rule (2004), Federal Register, Washington, D. C November 15
8. Centers for Medicare and Medicaid Services Calendar Year 2005 Ambulatory Surgical Center Interim Final Rule (2005), Federal Register, Washington, D. C May 4
9. Bachmann A., Ruszat R., Wyler S., Reich O., Seifert H.H., Müller A., and Sulser T. Photoselective vaporization of the prostate. the Basel experience after 108 procedures. Eur Urol 47 (2005) 798
10. Bachmann A., Schürch L., Ruszat R., Wyler S.F., Seifert H.H., Müller A., et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP). a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48 (2005) 965
11. Carter A., Sells H., and O'Boyle P.J. High-power KTP laser for the treatment of symptomatic benign prostatic enlargement. BJU Int 83 (1999) 857
12. Hai M.A., and Malek R.S. Photoselective vaporization of the prostate. initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17 (2003) 93
13. Malek R.S., Kuntzman R.S., and Barrett D.M. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate. observations on long-term outcomes. J Urol 174 (2005) 1344
14. Miki T., Kojima T., Nonomura N., Matsumiya K., Kokado Y., Yoshioka T., et al. Transurethral visual laser ablation of the prostate for benign prostatic hyperplasia using a KTP/YAG laser. Int J Urol 4 (1997) 576
15. Reich O., Bachmann A., Siebels M., Hofstetter A., Stief C.G., and Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173 (2005) 158
16. Sulser T., Reich O., Wyler S., Ruszat R., Casella R., Hofstetter A., et al. Photoselective KTP laser vaporization of the prostate. first experiences with 65 procedures. J Endourol 18 (2004) 976
17. Te A.E., Malloy T.R., Stein B.S., Ulchaker J.C., Nseyo U.O., Hai M.A., et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. 12-month results from the first United States multicenter prospective trial. J Urol 172 (2004) 1404
18. Costello A., Agarwal D., Crowe H., and Lynch W. Evaluation of interstitial diode laser therapy for treatment of benign prostatic hyperplasia. Tech Urol 5 (1999) 202
19. Daehlin L., and Hedlund H. Interstitial laser coagulation in patients with lower urinary tract symptoms from benign prostatic obstruction. treatment under sedoanalgesia with pressure-flow evaluation. BJU Int 84 (1999) 628
20. De la Rosette J., Muschter R., Lopez M., and Gillatt D. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode-laser system with temperature feedback. Br J Urol 80 (1997) 433
21. Diana M., Schettini M., and Gallucci M. Minimally invasive treatment of BPH with interstitial diode laser coagulation. Arch Ital Urol Androl 71 (1999) 1
22. Floratos D., Sonke G., Francisca E., Kiemeney L., Debruyne F., and de la Rosette J. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 56 (2000) 604
23. Greenberger M., and Steiner M. The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia. interim analysis. World J Urol 16 (1998) 386
24. Kochakarn W., Nilsakulwat S., Roongruangsilp U., and Muangman V. Interstitial laser coagulation for the treatment of benign prostatic hyperplasia. a 3 year follow-up of 30 cases. J Med Assoc Thai 84 (2001) 1126
25. Kursh E., Concepcion R., Chan S., Hudson P., Ratner M., and Eyre R. Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction. a randomized trial with 2-year follow-up. Urology 61 (2003) 573
26. Liedberg F., Adell L., Hagberg G., and Palmqvist I. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic hyperplasia. Scand J Urol Nephrol 37 (2003) 494
27. Martenson A., and de la Rosette J. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system. results of an evolving technology. Prostate Cancer Prostatic Dis 2 (1999) 148
28. Muschter R., de la Rosette J., Whitfield H., Pellerin J., Madersbacher S., and Gillatt D. Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 48 (1996) 223
29. Nishizawa K., Kobayashi T., Watanabe J., and Ogura K. Interstitial laser coagulation of the prostate for management of acute urinary retention. J Urol 170 (2003) 879
30. Nishizawa K., Kobayashi T., Mitsumori K., Watanabe J., and Ogura K. Intermittent catheterization time required after interstitial laser coagulation of the prostate. Urology 64 (2004) 79
31. Polepalle S., and Monga M. Interstitial laser therapy for benign prostatic hyperplasia in the anticoagulated patient. Tech Urol 7 (2001) 285
32. Tsui K., Chang P., Chang S., and Cheng H. Interstitial laser photocoagulation for treatment of benign prostatic hypertrophy. outcomes and cost effectiveness. Chang Gung Med J 26 (2003) 799
33. Williams J. Interstitial laser coagulation of the prostate. introduction of a volume-based treatment formula with 12-month follow-up. World J Urol 16 (1998) 392
34. Consumer Price Index: Medical Care Component. United States Department of Labor, Bureau of Labor Statistics. Available at http://data.bls.gov/cgi-bin/dsrv. Accessed November 2005
35. Mebust W.K., Holtgrewe H.L., Cockett A.T.K., Peters P.C., and Writing Committee. Transurethral prostatectomy. immediate and postoperative complications-a cooperative study of 143 participating institutions evaluating 3,885 patients. J Urol 141 (1989) 243